Advanced Enzyme Technologies
ADVENZYMES · Pharma > Pharmaceuticals & Drugs · Chairman: Vasant Rathi Listing date: Aug. 2, 2016 · Employees: 750 · Thane · http://www.advancedenzymes.com

Stock Price vs Company Growth
1d
0.3%
1w
0.7%
1m
8.1%
3m
1.8%
6m
27.8%
1y
45.5%
5y
16.3%
all
7.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 394 0.3%
340
425
Company Overview

Sales
605 Cr
Growth: 10.8%
Profit after Tax
137 Cr
Growth: 9.9%
Small Cap
4,408 Cr
P/E: 32.1x
Industry P/E: 35.0x
Fundamentals

Sales (Cr) ₹ 605
Growth 10.8%
EBITDA 32.0%
P/S 7.3x
Dividend 1.7%
P/E 32.1x
Book Value ₹ 120
PEG Ratio 3.0x
ROE 10.7%
P/B 3.3x
Shareholding Pattern

Institutions
Orbimed Asia Iii Mauritius Limited
9.89 %
Nalanda India Equity Fund Limited
4.74 %
Hdfc Small Cap Fund
4.39 %
Orbimed Asia Iii Mauritius Fvci Limited
2.2 %
Icici Prudential Esg Fund
2.14 %
Promoters
Vasant Rathi
32.72 %
Advanced Vital Enzymes Private Limited
8.91 %
Reshma Namita Rathi
2.37 %
Rasika Vasant Rathi
2.36 %
Rachana Vasant Rathi
2.36 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes.
Investors (84)
Followers (13)